News for SATELLOS BIOSCIENCE INC (MSCL.V)

[url="]Satellos Bioscience Inc.[/url] (TSX: MSCL, OTCQB: MSCLF) (”œSatellos” or the ”œCompany”), a biotech company developing new small molecule therapeu

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) has announced the appointment of Dr. Wildon Farwell as its new Chief Medical Officer. Dr. Farwell brings ext

[url="]Satellos Bioscience Inc.[/url] (TSX: MSCL, OTCQB: MSCLF) (”œSatellos” or the ”œCompany”), a biotech company developing new small molecule therapeu

All director nominees for Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) were elected with over 97% of the votes at the Annual and Special Meeting. Shar

[url="]Satellos Bioscience Inc.[/url] (TSX: MSCL, OTCQB: MSCLF) (”œSatellos” or the ”œCompany”), a biotech company developing new small molecule therapeu

Satellos Bioscience (TSX: MSCL, OTCQB: MSCLF) will participate in the 2025 Parent Project Muscular Dystrophy (PPMD) Annual Conference in Las Vegas. The

[url="]Satellos Bioscience Inc.[/url] (TSX: MSCL, OTCQB: MSCLF) (”œSatellos” or the ”œCompany”), a biotech company developing new small molecule therapeu

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (”œSatellos” or the ”œCompany”), a clinical-stage biotechnology company developing life-improving medi

TORONTO —

– Company remains on track to report Phase 1a data from both the Single- and Multiple-Ascending Dose (SAD and MAD) cohorts in the healthy volunteer portion of the s…

TORONTO — Satellos Bioscience Inc.

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (”œSatellos” or the ”œCompany”), a public biotech company developing new small molecule therapeutic ap

BASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS ON SEDAR+ BASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSP…

Satellos Announces Overnight Marketed Public Offering of Common Shares

[url="]Satellos Bioscience Inc.[/url] (TSX: MSCL, OTCQB: MSCLF) (”œSatellos” or the ”œCompany”), a public biotech company developing new small molecule t

–

[url="]Satellos Bioscience Inc.[/url] (TSX:MSCL, OTCQB:MSCLF) (”œSatellos”), a public biotech company developing new small molecule therapeutic approaches t

[url="]Satellos Bioscience Inc.[/url] (TSX:MSCL, OTCQB:MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic

TORONTO —